2012
DOI: 10.1007/s00428-012-1295-y
|View full text |Cite
|
Sign up to set email alerts
|

Clear cell sarcoma expressing a novel chimerical transcript EWSR1 exon 7/ATF1 exon 6

Abstract: Clear cell sarcoma harbours recurrent translocation, resulting in EWSR1/ATF1 or less commonly EWSR1/CREB1 fusion. To date, six types of EWSR1/ATF1 fusion have been reported, of which three are in-frame and encode functional proteins. We present a reverse transcription - polymerase chain reaction analysis of a tumour near the hallux of the right foot. The sequencing of obtained fragments revealed the presence of a novel chimerical transcript-the in-frame fusion between EWSR1 exon 7 and ATF1 exon 6 that represen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 9 publications
1
5
1
Order By: Relevance
“…Even functional landscape of CCS genome has been rendered by copy number observations in human tumors and genetic experiments in mice in a study 7 . Slight and focal positivity of S100 was observed in immunohistochemistry in this case, which was slightly different from the literature in which S100 reacted as strong positivity 3 . Noteworthily, CD117 negativity has been considered as an immunohistochemical feature that could differentiate CCS from MM, 9 which was also revealed as negative expression in our case.…”
Section: Discussioncontrasting
confidence: 55%
See 2 more Smart Citations
“…Even functional landscape of CCS genome has been rendered by copy number observations in human tumors and genetic experiments in mice in a study 7 . Slight and focal positivity of S100 was observed in immunohistochemistry in this case, which was slightly different from the literature in which S100 reacted as strong positivity 3 . Noteworthily, CD117 negativity has been considered as an immunohistochemical feature that could differentiate CCS from MM, 9 which was also revealed as negative expression in our case.…”
Section: Discussioncontrasting
confidence: 55%
“…6 Another chromosomal translocation [t (2;22) (q34; q12)] resulting in chimeric EWSR1/CREB1 gene fusion also drives sarcoma-genesis in CCS. 3,7 Recently, next-generation sequencing was performed to identify gene fusions with advantage of revealing chimerical types and fusion sites. 8 Even functional landscape of CCS genome has been rendered by copy number observations in human tumors and genetic experiments in mice in a study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…26,27 Fusion type is not related to behaviour. 174 Of EWSR1-ATF1 fusions, several different transcripts have been identified, 27,167,175,176 the most common of which fuses EWSR1 exon 8 and ATF1 exon 4. 27,53 In the resultant chimeric protein, the N-terminal domain of EWSR1 is linked to the basic leucine zipper (bZIP) domain of ATF1.…”
Section: L E a R C E L L S A R C O M A ( O F T E N D O N S A N D A mentioning
confidence: 99%
“…However, CCSTA often shows positivity for melanocytic markers (HMB45, Melan-A, and Tyrosinase), whereas GNET is often negative for melanocytic markers and is positive for synaptophysin [5]. These tumors share common genetic alterations: chromosomal translocation events t(12;22)(q13;q12) and t(2;22)(q34;q12), leading to chimeric fusion proteins EWSR1-ATF1 and EWSR1-CREB1 , respectively [3, 6]. …”
Section: Introductionmentioning
confidence: 99%